Kato N - Search Results

1

Percutaneous transluminal angioplasty for atherosclerotic stenosis of the intracranial cerebral arteries. initial results and long-term follow-up.

Hyodo A, Kato N, Nakai Y, Anno I, Sato H, Okazaki M, Matsumaru Y, Nose T. Hyodo A, et al. Among authors: kato n. Interv Neuroradiol. 1999 Nov;5 Suppl 1:27-32. doi: 10.1177/15910199990050S104. Epub 2001 May 15. Interv Neuroradiol. 1999. PMID: 20670534

2

Heparin also interacts with selectins and modulates the cell adhesion process.

Yanaka K, Kato N, Nose T. Yanaka K, et al. Among authors: kato n. Circulation. 2000 Nov 14;102(20):E169. doi: 10.1161/01.cir.102.20.e169. Circulation. 2000. PMID: 11076839 No abstract available.

3

Rapid spontaneous resolution of acute subdural hematoma occurs by redistribution--Two case reports.

Kato N, Tsunoda T, Matsumura A, Yanaka K, Nose T. Kato N, et al. Neurol Med Chir (Tokyo). 2001 Mar;41(3):140-3. doi: 10.2176/nmc.41.140. Neurol Med Chir (Tokyo). 2001. PMID: 11372558 Free article. Review.

4

Does antibody to the alpha4 integrin inhibit the function of lymphocytes and monocytes?

Yanaka K, Kato N, Nose T. Yanaka K, et al. Among authors: kato n. Stroke. 2001 Aug;32(8):1932-3. doi: 10.1161/01.str.32.8.1932. Stroke. 2001. PMID: 11486129 No abstract available.

5

Coil migration during endovascular treatment in a patient with Galenic arteriovenous malformation.

Hyodo A, Yanaka K, Kato N, Nose T. Hyodo A, et al. Among authors: kato n. J Clin Neurosci. 2002 Sep;9(5):584-5. doi: 10.1054/jocn.2002.0974. J Clin Neurosci. 2002. PMID: 12383422

6

Increased levels of lipid peroxides as predictive of symptomatic vasospasm and poor outcome after aneurysmal subarachnoid hemorrhage.

Kamezaki T, Yanaka K, Nagase S, Fujita K, Kato N, Nose T. Kamezaki T, et al. Among authors: kato n. J Neurosurg. 2002 Dec;97(6):1302-5. doi: 10.3171/jns.2002.97.6.1302. J Neurosurg. 2002. PMID: 12507127

7

Prevention of delayed cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

Yanaka K, Kamezaki T, Fujita K, Kato N, Nagase S, Hirayama A, Asakawa H, Yamazaki T, Nose T. Yanaka K, et al. Among authors: kato n. Drugs Today (Barc). 2001 Aug;37(8):573-578. doi: 10.1358/dot.2001.37.8.844172. Drugs Today (Barc). 2001. PMID: 12743639

8

Current and future therapies for ischemic cerebrovascular disease. II. Surgery and new treatments on the horizon.

Yanaka K, Sugimoto K, Yasuda M, Asakawa H, Kamezaki T, Kato N, Matsumaru Y, Nose T. Yanaka K, et al. Among authors: kato n. Drugs Today (Barc). 2001 Feb;37(2):75-84. doi: 10.1358/dot.2001.37.2.614845. Drugs Today (Barc). 2001. PMID: 12783100

9

The antioxidant EPC-K1 ameliorates brain injury by inhibiting lipid peroxidation in a rat model of transient focal cerebral ischaemia.

Kato N, Yanaka K, Nagase S, Hirayama A, Nose T. Kato N, et al. Acta Neurochir (Wien). 2003 Jun;145(6):489-93; discussion 493. doi: 10.1007/s00701-003-0036-z. Acta Neurochir (Wien). 2003. PMID: 12836074

10

Current and future therapies for ischemic cerebrovascular disease.

Yanaka K, Kujiraoka Y, Okazaki M, Asakawa H, Kato N, Matsumaru Y, Nose T. Yanaka K, et al. Among authors: kato n. Drugs Today (Barc). 2000 Dec;36(12):807-15. Drugs Today (Barc). 2000. PMID: 12845339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,958 results

Search Page

Filters